These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16973498)

  • 1. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
    Bassus S; Wegert W; Krause M; Escuriola-Ettinghausen C; Siegemund A; Petros S; Scholz T; Scharrer I; Kreuz W; Engelmann L; Kirchmaier CM
    Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
    Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
    Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.
    Knappe S; Gorczyca ME; Jilma B; Derhaschnig U; Hartmann R; Palige M; Scheiflinger F; Dockal M
    Thromb Haemost; 2013 Mar; 109(3):450-7. PubMed ID: 23348798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characteristics of N8, a new recombinant FVIII.
    Christiansen ML; Balling KW; Persson E; Hilden I; Bagger-Sørensen A; Sørensen BB; Viuff D; Segel S; Klausen NK; Ezban M; Lethagen S; Steenstrup TD; Kjalke M
    Haemophilia; 2010 Nov; 16(6):878-87. PubMed ID: 20546031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test - Demonstrated in vitro and ex vivo.
    Madsen DE; Nichols TC; Merricks EP; Waters EK; Wiinberg B
    PLoS One; 2017; 12(4):e0175030. PubMed ID: 28384182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma.
    Vila V; Aznar JA; Moret A; Marco A; Navarro S; Vila C; España F
    Haemophilia; 2013 Mar; 19(2):318-21. PubMed ID: 23174035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets significantly modify procoagulant activities in haemophilia A.
    Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
    Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
    Salvagno GL; Astermark J; Lippi G; Ekman M; Franchini M; Guidi GC; Berntorp E
    Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.
    Dargaud Y; Béguin S; Lienhart A; Al Dieri R; Trzeciak C; Bordet JC; Hemker HC; Negrier C
    Thromb Haemost; 2005 Mar; 93(3):475-80. PubMed ID: 15735797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?
    Salinas V; Carmona R; Mohammed BM; Martin EJ; Brophy DF; Young G
    Haemophilia; 2015 May; 21(3):398-404. PubMed ID: 25495850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.
    Jha NK; Shestopal SA; Gourley MJ; Woodle SA; Liang Y; Sarafanov AG; Weinstein M; Ovanesov MV
    Haemophilia; 2016 Sep; 22(5):780-9. PubMed ID: 27038076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prophylactic factor VIII in severe haemophilia A.
    Gissel M; Whelihan MF; Ferris LA; Mann KG; Rivard GE; Brummel-Ziedins KE
    Haemophilia; 2012 Mar; 18(2):193-9. PubMed ID: 21899664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay.
    Baumgartner CK; Zhang G; Kuether EL; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2015 Dec; 13(12):2210-9. PubMed ID: 26453193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
    Radtke KP; Griffin JH; Riceberg J; Gale AJ
    J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.
    Karpf DM; Kjalke M; Thim L; Agersø H; Merricks EP; Defriess N; Nichols TC; Ezban M
    Haemophilia; 2011 Sep; 17(5):e963-8. PubMed ID: 21682818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.